As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries to build a role of the drug alongside rival therapies ...

Meanwhile, Nuvama is estimating Divi's revenue will grow 20% YoY driven by strong showing in Sacubitril/Valsartan. Divi's gross margins are likely to improve 70 bps QoQ to 59.3%. Divi's overall ...

Pedraza-Cruz, P. , Varghese, M. , DiGiacomo, D. , Spencer, C. and Horani, O. (2025) Adrenal Crisis Secondary to Bilateral Adrenal Hemorrhage in a Patient with Hypercoagulable Disorder. Case Reports in ...

If you have lupus, you’re at a higher risk for a heart attack or stroke. Up to 74% of people with lupus also have high blood pressure. To lower your likelihood of cardiovascular issues and other ...

Dozens of different medications can help treat high blood pressure (hypertension). These medications are called antihypertensives and are divided into many different categories, each of which ...

Flying with unmanaged high blood pressure may carry additional risk. You can manage your blood pressure before your trip to limit your chances of developing complications. For many people, a fear ...

We evaluated the novel use of valsartan to attenuate the occurrence of and progression of pulmonary vein stenosis following total anomalous pulmonary venous connection surgery. Subclinical pulmonary ...

Pharmacological options for sRV failure remain poorly defined. This study aims to investigate the tolerability and effects of sacubitril/valsartan on sRV failure in adult patients with sRV. Methods In ...

He then explores the effect of race and sacubitril/valsartan use in HF patients documented in a pooled analysis of the PARADIGM-HF and PARAGON-HF trials. Finally, Dr. Eagle discusses the utility of ...